Table 1

Frequency and characteristics of the IGH rearrangements found by the capture/sequencing methodology in DLBCLs

GroupCases (%)IGH locus bkp mapping (cases)
No IGH fusion 44 (61%)  
IGH fusion 28* (39%) DHJH (16); VHJH (1); DH (1); Sγ (7); Sµ (3); Sα (3) 
IGH-BCL2 16 (22%) DHJH (14); VHJH(1); Sα (1) 
IGH-BCL6 6 (8.3%) Sγ (4); Sμ (2) 
IGH-MYC 3 (4.1%) Sα (2); DH (1) 
IGH-CCDN1 2 (2.7%) DHJH (2) 
IGH-IRF8 2 (2.7%) Sγ (1); Sμ (1) 
IGH-EBF1 1 (1.4%) Sγ (1) 
IGH-EIF4A1/TNFSF13 1 (1.4%) Sγ (1) 
 Total 72  
GroupCases (%)IGH locus bkp mapping (cases)
No IGH fusion 44 (61%)  
IGH fusion 28* (39%) DHJH (16); VHJH (1); DH (1); Sγ (7); Sµ (3); Sα (3) 
IGH-BCL2 16 (22%) DHJH (14); VHJH(1); Sα (1) 
IGH-BCL6 6 (8.3%) Sγ (4); Sμ (2) 
IGH-MYC 3 (4.1%) Sα (2); DH (1) 
IGH-CCDN1 2 (2.7%) DHJH (2) 
IGH-IRF8 2 (2.7%) Sγ (1); Sμ (1) 
IGH-EBF1 1 (1.4%) Sγ (1) 
IGH-EIF4A1/TNFSF13 1 (1.4%) Sγ (1) 
 Total 72  
*

Of 72 samples with adequate coverage, 51 are nodal DLBCLs, and 21 are extranodal tumors. The incidence of IGH fusions was 43% in the nodal subset and 28% in the extranodal group.

Three IGH-BCL2–positive samples had a second fusion (supplemental Table 3).

Close Modal

or Create an Account

Close Modal
Close Modal